Payment overview · 2025
General Payments
$457.33
10 reported records · 1 companies
Healthcare provider profile · identity verified
Mark John Moe, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · LITTLE FALLS, MN · NPI 1902821937
Verified facts
What the public records show
CMS Open Payments records show Mark John Moe, M.D. received $457.33 in general payments during 2025 across 10 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $457.33 | 100.0% | 10 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $457.33 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ASSURITY Normalized: assurity |
Device | Abbott Laboratories | $310.66 | 7 | 2025 |
Source payment records
|
|||||
| GALLANT Normalized: gallant |
Device | Abbott Laboratories | $146.67 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 533 | 122 |
| Levothyroxine Sodium | Levothyroxine Sodium | 433 | 103 |
| Simvastatin | Simvastatin | 334 | 75 |
| Metoprolol Succinate | Metoprolol Succinate | 332 | 83 |
| Losartan Potassium | Losartan Potassium | 318 | 78 |
| Lisinopril | Lisinopril | 300 | 78 |
| Omeprazole | Omeprazole | 284 | 68 |
| Amlodipine Besylate | Amlodipine Besylate | 279 | 71 |
| Gabapentin | Gabapentin | 276 | 55 |
| Spironolactone | Spironolactone | 239 | 54 |
| Metformin Hcl | Metformin Hcl | 235 | 47 |
| Furosemide | Furosemide | 233 | 61 |
| Warfarin Sodium | Warfarin Sodium | 223 | 39 |
| Carvedilol | Carvedilol | 191 | 42 |
| Pantoprazole Sodium | Pantoprazole Sodium | 177 | 39 |
| Potassium Chloride | Potassium Chloride | 164 | 39 |
| Duloxetine Hcl | Duloxetine Hcl | 160 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 159 | 26 |
| Eliquis | Apixaban | 153 | 28 |
| Tamsulosin Hcl | Tamsulosin Hcl | 146 | 35 |
| Allopurinol | Allopurinol | 145 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 139 | 33 |
| Prednisone | Prednisone | 139 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 138 | 36 |
| Jardiance | Empagliflozin | 128 | 27 |
| Oxycodone Hcl | Oxycodone Hcl | 126 | 17 |
| Tramadol Hcl | Tramadol Hcl | 114 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 107 | 29 |
| Sertraline Hcl | Sertraline Hcl | 106 | 25 |
| Montelukast Sodium | Montelukast Sodium | 101 | 24 |
| Metformin Hcl Er | Metformin Hcl | 98 | 26 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 98 | 27 |
| Trazodone Hcl | Trazodone Hcl | 96 | 20 |
| Lorazepam | Lorazepam | 84 | 14 |
| Famotidine | Famotidine | 83 | 23 |
| Glipizide Er | Glipizide | 83 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 77 | 16 |
| Meloxicam | Meloxicam | 75 | 16 |
| Finasteride | Finasteride | 73 | 15 |
| Xarelto | Rivaroxaban | 73 | 22 |
| Clonazepam | Clonazepam | 72 | 13 |
| Sucralfate | Sucralfate | 69 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 65 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 65 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 64 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 62 | 18 |
| Doxazosin Mesylate | Doxazosin Mesylate | 62 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 61 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 61 | suppressed |
| Ozempic | Semaglutide | 60 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 58 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 58 | suppressed |
| Baclofen | Baclofen | 56 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 54 | 12 |
| Alprazolam | Alprazolam | 51 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 51 | 21 |
| Synthroid | Levothyroxine Sodium | 51 | 11 |
| Benazepril Hcl | Benazepril Hcl | 50 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | suppressed |
| Pregabalin | Pregabalin | 50 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 49 | suppressed |
| Sotalol | Sotalol Hcl | 47 | 12 |
| Lamotrigine | Lamotrigine | 45 | suppressed |
| Mirtazapine | Mirtazapine | 44 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 44 | suppressed |
| Methotrexate | Methotrexate Sodium | 42 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 41 | 12 |
| Torsemide | Torsemide | 41 | 17 |
| Digoxin | Digoxin | 40 | suppressed |
| Trospium Chloride | Trospium Chloride | 39 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 38 | suppressed |
| Methocarbamol | Methocarbamol | 38 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 38 | suppressed |
| Atenolol | Atenolol | 37 | 11 |
| Azithromycin | Azithromycin | 36 | 18 |
| Glipizide | Glipizide | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 33 | suppressed |
| Chlorthalidone | Chlorthalidone | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 32 | suppressed |
| Metolazone | Metolazone | 31 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 29 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 28 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 13 |
| Trulicity | Dulaglutide | 28 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 26 | suppressed |
| Bumetanide | Bumetanide | 26 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 26 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Leflunomide | Leflunomide | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Pentoxifylline | Pentoxifylline | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Humira(Cf) Pen | Adalimumab | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 19 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 19 | suppressed |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 15 |
| Dexamethasone | Dexamethasone | 16 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 16 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 12 |
| Glimepiride | Glimepiride | 16 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Restasis | Cyclosporine | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Celecoxib | Celecoxib | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Olanzapine | Olanzapine | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Juluca | Dolutegravir/Rilpivirine | 11 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $457.33 · 10 records | Abbott Laboratories | ASSURITY, GALLANT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error